ArticleCancers2026

Epigenetic Priming with Oral Decitabine/Cedazuridine Combined with Nivolumab in Unresectable or Metastatic Mucosal Melanoma: Clinical and Correlative Findings from a Phase Ib/II Trial.

Jessica S W Borgers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.